Vevo F2 Imaging System

Predicted recompete opportunity based on federal award data.
Current Contract: 75N98026P00726 Incumbent: FUJIFILM VISUALSONICS CORP Contract Value: $396,186.4 Potential End Date: 2026-10-09T00:00:00.000Z Competition: COMPETED UNDER SAP Pricing: FIRM FIXED PRICE Classification: recompete-likely (Confidence: medium - 65/100)

This notice is a combined synopsis/solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 “Streamlined Procedures for Evaluation and solicitation for commercial Items,” as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation (a written solicitation will not be issued) and quotes are being requested. The Solicitation number is RFQ-NIAID-26- 04446 and the solicitation is issued as a Request for Quotes (RFQ).

This acquisition will be processed under FAR Part 13 Simplified Acquisition Procedures (SAP). The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2024-05 dated May 22, 2024.

The North American Industry Classification System (NAICS) code for this procurement is 334510, Electromedical and Electrotherapeutic Apparatus Manufacturing, with a small business size standard of 1,250 employees. The requirement is being competed with a brand name restriction, and without a small business set-aside.

A high-resolution ultrasound imaging system is required to enable precise, real-time visualization of mouse embryos during in utero injection procedures. This capability is essential for accurate targeting of embryonic structures, improving procedural consistency, and increasing overall success rates. The system will support a range of applications including developmental biology studies, gene delivery, and disease modeling that depend on reliable embryonic manipulation.

Ultrasound guidance will reduce technical variability, minimize embryo loss, and allow confirmation of injection placement during procedures. The equipment is necessary to ensure efficient execution of ongoing and future research protocols that cannot be performed with sufficient accuracy using current methods.

NIH has a requirement for the following Brand Name Supplies:

Item(s) Serial/Product No.  Quantity

Fujifilm Visualsonics Vevo Imaging System Vs -20076 - 1

3D Mode Software 12314 - 1

Power Dopler Mode 11952 - 1

Vevo Lab analysis software Vs20034 - 1

57 MHz transducer 53297 - 1

71 MHz transducer 53295 - 1

Vevo transducer port cover - 53709 - 1

Vevo Animal monitor Mouse platform - 53610 - 1

MX/UHFX series transducer array cover 51144 - 1

Vevo imaging Station 2 VS 20085 - 1

Vevo animal monitor Rat platform 53611 - 1

Vevo compat Dual Anesthesia System VS 12055 - 1

H Type regulator 10414 - 1

h type medical air regulator 11830 - 1

9 mm Bain Circuit 11486 - 1

Introductory 2 day training  12353 - 1

Vevo System installation 12370 - 1

Vevo standard protection service - 51263 - Qty 4

Shipping/Freight (if applicable)

Place of Performance: NIH, 9000 Rockville Pike, Building 10, Bethesda, MD 20892, United States.  FOB: Destination

Delivery: Delivery estimate is 90 days after receipt and acceptance of award.

The government intends to award a firm fixed price purchase order to the responsible contractor as a result of this RFQ that will include the terms and conditions set forth herein.  The award will be based on the following: technical capability to meet the requirements, price, and delivery. 

By submitting a quote in response to this solicitation, vendor is accepting the following terms and conditions:

The following FAR provisions apply to this acquisition:

FAR 52.212-1 Instructions to Offerors Commercial Items (SEP 2023)

FAR 52.212-3 Offerors Representations and Certifications - Commercial Items (MAY 2024)

FAR 52.204-7 System for Award Management (OCT 2018)

(Offerors must complete annual representations and certifications on-line at http://www.sam.gov/ in accordance with FAR 52.212-3 Offerors Representations and Certifications- Commercial Items (Please ensure FAR 52.209-2 -- Prohibition on Contracting with Inverted Domestic Corporations--Representation. (Nov 2015) is updated in your SAM record)

FAR 52.203-18 Prohibition on Contracting with Entities that Require Certain Internal Confidentiality Agreements – Representation (JAN 2017)

FAR 52.204–26 Covered Telecommunications Equipment or Services-Representation

(OCT 2020) *** Must complete representation if attached to this solicitation- see attachment 52.204-26

The following FAR contract clauses apply to this acquisition:

FAR 2.212-4 Contract Terms and Conditions Commercial Items (NOV 2023)

FAR 52.232-40 Providing Accelerated Payments to Small Business Subcontractors (MAR 2023)

FAR 52.204-13 System for Award Management Maintenance (OCT 2018)

FAR 52.204-25 Prohibition on Contracting for Certain Telecommunications and Video Surveillance Services or Equipment (NOV 2021)
HHSAR 352.222-70, Contractor Cooperation in Equal Employment Opportunity Investigations (December 2015)

FAR 52.252-2 -- Clauses Incorporated by Reference. (Feb 1998)

This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at this address:  http://farsite.hill.af.mil/vffara.htm

By submission of an offer, the offeror acknowledges the requirement that a prospective awardee shall be registered in the System for Award Management (SAM) database prior to award, during performance, and through final payment of any contract, basic agreement, basic ordering agreement, or blanket purchasing agreement resulting from this solicitation (www.sam.gov).

Copies of the above-referenced provisions and clauses are available from http://www.acquisition.gov/far/loadmainre.html & http: //www.hhs.gov/regulation/index.html or, upon request, either by telephone or fax.

Submission shall be received not later than June 5, 2026 @ 5:00 PM EST

Offers may be e-mailed to Linda Smith (contact@example.gov) or Jessica Emerson at contact@example.gov.  Offers shall include RFQ number in the subject line (RFQ- NIAID-26- 04446). Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f).

All responsible sources may submit an offer that will be considered by this Agency. 

Any questions or concerns regarding this solicitation should be forwarded in writing via e-mail to Jessica Emerson @ contact@example.gov